Scientists measure 'Hunger Hormone' after a meal in obesity study
NCT ID NCT07627802
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at how levels of ghrelin, a hormone that controls hunger, change after eating a standardized meal in 80 adults aged 40-60 with different body weights. Participants drank a nutritional supplement, and their blood was tested over several hours. The goal was to understand if people with obesity have different appetite hormone responses compared to those with normal weight.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Nutridrink Protein (oral nutritional supplement)
What this could lead to
If successful, this could help explain how appetite hormones differ in people with obesity, potentially guiding future weight management strategies.
What could go wrong
This is a small, completed observational study, not a treatment trial. Results may not apply to broader populations or lead directly to new therapies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medical University of Bialystok
Bialystok, Poland, 15-089, Poland